Lucid

We are thrilled to announce that the Lucid Group has just received our Silver Award Ecovadis Certification in our first ever group wide submission, after receiving a Bronze Award for DiD in the US last year. Ecovadis is the international sustainability standard and is the world’s largest and most trusted provider of business sustainability ratings. […]

On Friday 28 July, nine colleagues from our Rubix team headed to the Peak District to volunteer their time and help care for its precious wild landscape. This was as part of our Lucid Spirit programme, an initiative set up to give back to communities and the environment. The team were guided by Rob Kenning

The UN Global Compact is the world’s largest corporate sustainability initiative that invites companies to align their culture, strategies and operations with universal principles on human rights, labour, environment and anti-corruption and take actions that advance societal goals. The attached letter (link to supplied file UN_Compact_Letter.pdf): from Sanda Ojiambo (Executive Director United Nations Global Compact) to our

At Lucid, we pride ourselves not on just understanding science, but also understanding the clinical environment and implications. . Here’s our latest insight report, focused on IBD from Digestive Disease Week in Chicago, created in collaboration with the wonderful Jennie Clough and Joshua McGuire.  #lucidlife #clinicalinsight #ddwsummary  .

Lucid Group has acquired the leading consulting firm, Synetic Life Sciences. The combined capabilities of Lucid and Synetic represents a unique value proposition for the industry, providing clients with an end-to-end partnership across the development and commercialisation journey, delivering transformative solutions across clients’ organisational needs and brand opportunities. It is a significant step forward for Lucid

We at Lucid are pioneers, transforming the world of healthcare communications, shaping the industry and helping our clients to reach more patients and realise the potential of their medicines. We believe strongly that a successful organisation starts by enabling every single person to be their whole selves, no matter who they love. But none of

In April’s PME, Danny Buckland has been talking to industry leaders about launch excellence in the featured article, Listen, learn and lift off. . Buckland points out that pandemic storms have changed the atmospherics of product launches, which now fire off at all angles and timings – like a box of fireworks introduced to a stray

In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines today.  With a rapidly changing clinical, economic and regulatory environment, the launch of new products has catapulted the pharmaceutical industry into greater complexity and pressure

In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.  Why is raising awareness of rare diseases so important? Because 300 million people worldwide are living with a rare disease. This means that, collectively, the number of people living with a rare disease

Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. The global rare disease community and its supporters come together on this day to call for more equitable access to social opportunity, treatment and support for people living with a rare disease, their families and carers.  In support